Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Melissa R Junttila

7PUBLICATIONS

83CO-AUTHORS

Molecular targetsPredictive and prognostic markersMedical infection agents (incl. prions)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Nov 06, 2025

Enozertinib Is a Selective, Brain-Penetrant EGFR Inhibitor for Treating Non-Small Cell Lung Cancers with EGFR Exon 20 and Atypical Mutations.

Melissa R Junttila, Claire E Repellin, Sumeet Salaniwal

|Aug 23, 2024

ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors.

Christopher T Chen, Vishesh Khanna, Shivaani Kummar

|Jan 16, 2024

Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide.

Wassim Abida, Andrew W Hahn, Neal Shore

|Sep 11, 2023

A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer.

M Dorso, Payal T Patel, Aleksandr Pankov

|Aug 19, 2022

EHMT2 methyltransferase governs cell identity in the lung and is required for KRAS <sup>G12D</sup> tumor development and propagation.

Ariel Pribluda, Anneleen Daemen, Anthony Nelson Lima

|Oct 07, 2020

Transcriptional Subtypes Resolve Tumor Heterogeneity and Identify Vulnerabilities to MEK Inhibition in Lung Adenocarcinoma.

Anneleen Daemen, Jonathan E Cooper, Szymon Myrta

Pageof 2

Frequent Collaborators

5 joint publications

Anneleen Daemen

3 joint publications

Edna Chow Maneval

3 joint publications

Pratik S Multani

3 joint publications

Aleksandr Pankov

2 joint publications

Rongda Xu

2 joint publications

Shravani R Barkund

2 joint publications

Maureen Duff

2 joint publications

Erica L Jackson

2 joint publications

Rupal Patel

2 joint publications

Lori S Friedman

Frequent Collaborators

5 joint publications

Anneleen Daemen

3 joint publications

Edna Chow Maneval

3 joint publications

Pratik S Multani

3 joint publications

Aleksandr Pankov

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

High-Throughput <em>In Vitro</em> Assay using Patient-Derived Tumor Organoids

High-Throughput <em>In Vitro</em> Assay using Patient-Derived Tumor Organoids

Published on : Jun 14, 2021

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on : May 19, 2022

See more related videos

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

High-Throughput <em>In Vitro</em> Assay using Patient-Derived Tumor Organoids

High-Throughput <em>In Vitro</em> Assay using Patient-Derived Tumor Organoids

Published on : Jun 14, 2021

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on : May 19, 2022

See more related videos